The global Industrial Bioprocessing Market Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments -By Type (Upstream Bioprocessing, Downstream Bioprocessing), By Application (Food, Medical).
Industrial bioprocessing involves the use of biological systems such as microorganisms, enzymes, and cells to produce chemicals, pharmaceuticals, biofuels, and other valuable products in industrial-scale processes. One key trend shaping the future of industrial bioprocessing is the advancement of biotechnological tools and techniques to enhance process efficiency, product yields, and sustainability while reducing production costs and environmental impact. Bioprocess engineers and biotechnologists are leveraging advances in synthetic biology, metabolic engineering, and systems biology to engineer microorganisms with optimized pathways for target compound synthesis, enabling the production of complex molecules with high purity and specificity. Additionally, advancements in bioreactor design, process monitoring, and control systems are improving scalability, reproducibility, and automation of bioprocessing operations, facilitating the transition from batch to continuous production modes and reducing time-to-market for bioproducts. Moreover, the integration of bioprocessing with renewable feedstocks such as lignocellulosic biomass, agricultural residues, and waste streams is promoting sustainability and circular economy principles, enabling the utilization of non-food resources and reducing dependency on fossil fuels. As industries seek sustainable and cost-effective alternatives to traditional chemical processes, the industrial bioprocessing industry is poised for innovation and growth, with opportunities for collaboration, technology transfer, and market expansion to meet the evolving needs of manufacturers, biotech companies, and consumers.
The market report analyses the leading companies in the industry including 3M Company, Applikon Biotechnology B.V., BD Biosciences, Biopharm International, Cesco Bioengineering Co. Ltd, Danaher Corp, Eppendorf AG, Finesse Solutions Inc (Thermo Fisher Scientific), GE Healthcare, Merck KGaA, Sartorius Stedim Biotech, Thermo Fisher Scientific Inc.
A prominent trend in the market for Industrial Bioprocessing is the ongoing shift towards sustainable and renewable manufacturing practices across various industries. With increasing awareness of environmental concerns, resource scarcity, and climate change, there is a growing emphasis on adopting bioprocessing technologies that utilize renewable feedstocks, biodegradable materials, and environmentally friendly processes. Industrial bioprocessing offers sustainable alternatives to conventional manufacturing methods by harnessing biological organisms such as bacteria, yeast, and enzymes to produce a wide range of bio-based products, including biofuels, bioplastics, biochemicals, and biopharmaceuticals. Companies are investing in biorefineries, fermentation facilities, and bioprocessing equipment to scale up production of bio-based materials and chemicals, driving the transition towards a bioeconomy that is based on renewable resources and circular principles. This is driven by factors such as regulatory mandates, consumer preferences, and corporate sustainability commitments, leading to continued growth and innovation in the industrial bioprocessing sector.
The market for Industrial Bioprocessing is being driven by the growing demand for bio-based products and sustainable solutions in response to environmental and economic challenges. Industries such as chemicals, agriculture, food and beverage, pharmaceuticals, and cosmetics are seeking alternatives to fossil-based raw materials and petrochemical derivatives, driven by concerns about resource depletion, carbon footprint, and supply chain resilience. Bioprocessing technologies offer a sustainable pathway to produce high-value products from renewable feedstocks such as biomass, agricultural residues, and organic waste, reducing reliance on non-renewable resources and mitigating environmental impact. Additionally, consumer preferences for eco-friendly products, regulatory incentives for biofuels and renewable chemicals, and corporate sustainability goals are driving market demand for bio-based materials and bioprocessing solutions. Factors such as technological advancements, cost competitiveness, and scalability of bioprocessing technologies further accelerate market adoption and investment in industrial bioprocessing infrastructure, supporting market growth and development worldwide.
An exciting opportunity within the market for Industrial Bioprocessing lies in the integration of bioprocessing with digitalization and automation technologies to enhance process efficiency, productivity, and sustainability. Companies can explore opportunities to deploy advanced analytics, artificial intelligence, and robotics in bioprocessing operations to optimize fermentation processes, monitor microbial cultures, and control production parameters in real-time. By implementing data-driven decision-making tools, predictive modeling algorithms, and remote monitoring systems, bioprocessing facilities can improve process control, reduce variability, and increase yield and throughput. Additionally, there is potential to integrate bioprocessing equipment with industrial internet of things (IIoT) platforms, cloud-based data analytics, and smart sensors to enable remote operation, predictive maintenance, and continuous process optimization. By embracing digitalization and automation solutions, companies can enhance the efficiency, flexibility, and sustainability of industrial bioprocessing operations, driving cost savings, product quality improvements, and market competitiveness in the rapidly evolving bio-based economy.
The industrial bioprocessing market encompasses diverse stages, each involving significant contributions from various companies. Feedstock production involves agricultural giants including Archer Daniels Midland Company (ADM) and Cargill, which cultivate crops including corn and sugarcane for bio-based products. Additionally, sustainable forestry companies contribute wood biomass as a feedstock, while waste management firms including Veolia Environnement and Waste Management, Inc. process organic waste streams for bioconversion. In research and development, biotechnology companies including Amyris and Novozymes lead efforts in developing new enzymes, fermentation processes, and bio-based products, typically collaborating with universities and research institutions.
Bioprocess design and engineering services are provided by firms including Fluor Corporation and Bechtel Corporation, facilitating the construction of large-scale bioprocessing facilities. Equipment and instrument manufacturers including GEA Group and Thermo Fisher Scientific produce fermentation tanks, bioreactors, and analytical instruments crucial for bioprocessing operations. Companies including Cargill and DowDuPont are prominent bioproduct manufacturers, producing industrial enzymes, bioplastics, and biofuels. Contract manufacturing organizations including Lonza Group Ltd and Boehringer Ingelheim offer bioprocessing capabilities for contract manufacturing needs. Chemical distributors including Brenntag and Univar Solutions handle the distribution of bio-based products to various industries, while large bioproduct manufacturers opt for direct sales to provide customized solutions. End-users span diverse sectors including the chemical industry, food and beverage industry, pharmaceutical and medical industry, energy industry, agriculture industry, and other applications.
The downstream bioprocessing segment is the largest sector in the Industrial Bioprocessing Market, driven by diverse crucial factors. Downstream bioprocessing involves the purification, separation, and recovery of biomolecules produced in upstream bioprocessing, making it an indispensable stage in biopharmaceutical and biotechnology manufacturing. The increasing demand for biopharmaceuticals, including monoclonal antibodies, vaccines, and therapeutic proteins, has propelled the growth of downstream bioprocessing. With advancements in biotechnology and genetic engineering, there's a growing pipeline of complex biologics requiring sophisticated downstream processing techniques, further fueling the expansion of this segment. In addition, stringent regulatory requirements for the production of biopharmaceuticals necessitate efficient downstream processing to ensure product quality and safety, driving investments in this sector. Additionally, the scalability and efficiency of downstream bioprocessing technologies make them essential for large-scale production, solidifying the segment's position as the largest in the industrial bioprocessing market.
The medical segment is the fastest-growing sector in the Industrial Bioprocessing Market, driven by diverse pivotal factors. With the increasing prevalence of chronic diseases and the growing aging population worldwide, there's a rising demand for advanced medical treatments and therapies, including biopharmaceuticals and regenerative medicines. Industrial bioprocessing plays a crucial role in the production of these innovative medical solutions, such as monoclonal antibodies, cell and gene therapies, and tissue engineering products. Further, the rapid advancements in biotechnology, including CRISPR-Cas9 gene editing and mRNA technology, have expanded the scope of medical bioprocessing, leading to the development of cutting-edge treatments for various diseases. Additionally, the ongoing COVID-19 pandemic has highlighted the importance of bioprocessing in vaccine development and production, further accelerating growth in the medical segment. As research continues to push the boundaries of medical innovation, the medical segment of the industrial bioprocessing market is poised for sustained expansion, offering significant opportunities for industry players.
By Type
Upstream Bioprocessing
Downstream Bioprocessing
By Application
Food
Medical
3M Company
Applikon Biotechnology B.V.
BD Biosciences
Biopharm International
Cesco Bioengineering Co. Ltd
Danaher Corp
Eppendorf AG
Finesse Solutions Inc (Thermo Fisher Scientific)
GE Healthcare
Merck KGaA
Sartorius Stedim Biotech
Thermo Fisher Scientific Inc
*- List Not Exhaustive
TABLE OF CONTENTS
1 Introduction to 2024 Industrial Bioprocessing Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Industrial Bioprocessing Market Size Outlook, $ Million, 2021 to 2030
3.2 Industrial Bioprocessing Market Outlook by Type, $ Million, 2021 to 2030
3.3 Industrial Bioprocessing Market Outlook by Product, $ Million, 2021 to 2030
3.4 Industrial Bioprocessing Market Outlook by Application, $ Million, 2021 to 2030
3.5 Industrial Bioprocessing Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Industrial Bioprocessing Industry
4.2 Key Market Trends in Industrial Bioprocessing Industry
4.3 Potential Opportunities in Industrial Bioprocessing Industry
4.4 Key Challenges in Industrial Bioprocessing Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Industrial Bioprocessing Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Industrial Bioprocessing Market Outlook by Segments
7.1 Industrial Bioprocessing Market Outlook by Segments, $ Million, 2021- 2030
By Type
Upstream Bioprocessing
Downstream Bioprocessing
By Application
Food
Medical
8 North America Industrial Bioprocessing Market Analysis and Outlook To 2030
8.1 Introduction to North America Industrial Bioprocessing Markets in 2024
8.2 North America Industrial Bioprocessing Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Industrial Bioprocessing Market size Outlook by Segments, 2021-2030
By Type
Upstream Bioprocessing
Downstream Bioprocessing
By Application
Food
Medical
9 Europe Industrial Bioprocessing Market Analysis and Outlook To 2030
9.1 Introduction to Europe Industrial Bioprocessing Markets in 2024
9.2 Europe Industrial Bioprocessing Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Industrial Bioprocessing Market Size Outlook by Segments, 2021-2030
By Type
Upstream Bioprocessing
Downstream Bioprocessing
By Application
Food
Medical
10 Asia Pacific Industrial Bioprocessing Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Industrial Bioprocessing Markets in 2024
10.2 Asia Pacific Industrial Bioprocessing Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Industrial Bioprocessing Market size Outlook by Segments, 2021-2030
By Type
Upstream Bioprocessing
Downstream Bioprocessing
By Application
Food
Medical
11 South America Industrial Bioprocessing Market Analysis and Outlook To 2030
11.1 Introduction to South America Industrial Bioprocessing Markets in 2024
11.2 South America Industrial Bioprocessing Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Industrial Bioprocessing Market size Outlook by Segments, 2021-2030
By Type
Upstream Bioprocessing
Downstream Bioprocessing
By Application
Food
Medical
12 Middle East and Africa Industrial Bioprocessing Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Industrial Bioprocessing Markets in 2024
12.2 Middle East and Africa Industrial Bioprocessing Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Industrial Bioprocessing Market size Outlook by Segments, 2021-2030
By Type
Upstream Bioprocessing
Downstream Bioprocessing
By Application
Food
Medical
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
3M Company
Applikon Biotechnology B.V.
BD Biosciences
Biopharm International
Cesco Bioengineering Co. Ltd
Danaher Corp
Eppendorf AG
Finesse Solutions Inc (Thermo Fisher Scientific)
GE Healthcare
Merck KGaA
Sartorius Stedim Biotech
Thermo Fisher Scientific Inc
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Type
Upstream Bioprocessing
Downstream Bioprocessing
By Application
Food
Medical
Countries Analyzed
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Global Industrial Bioprocessing is forecast to reach $22.7 Billion in 2030 from $11.2 Billion in 2024, registering a CAGR of 12.5% over the outlook period
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
3M Company, Applikon Biotechnology B.V., BD Biosciences, Biopharm International, Cesco Bioengineering Co. Ltd, Danaher Corp, Eppendorf AG, Finesse Solutions Inc (Thermo Fisher Scientific), GE Healthcare, Merck KGaA, Sartorius Stedim Biotech, Thermo Fisher Scientific Inc
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: Revenue (USD); Volume